Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea-Reference-Cited by-同舟云学术

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea

Published:2017-03-31 Issue:1 Volume:36 Page:68-78
ISSN:2211-9140
Container-title:Kidney Research and Clinical Practice
language:en
Short-container-title:Kidney Res Clin Pract.

Author:

Cha Ran-hui¹,Kang Shin Wook²,Park Cheol Whee³,Cha Dae Ryong⁴,Na Ki Young⁵⁶,Kim Sung Gyun⁷,Yoon Sun Ae⁸,Kim Sejoong⁵⁶,Han Sang Youb⁹,Park Jung Hwan¹⁰,Chang Jae Hyun¹¹,Lim Chun Soo⁶¹²,Kim Yon Su⁶¹³

Affiliation:

1. Department of Internal Medicine, National Medical Center, Seoul, Korea

2. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

3. Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea

4. Department of Internal Medicine, Korea University Ansan-Hospital, Korea University College of Medicine, Seoul, Korea

5. Department of Internal Medicine, Seoul National University Bundang Hopsital, Seongnam, Korea

6. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

7. Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea

8. Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea, Uijeongbu, Korea

9. Department of Internal Medicine, Inje University Ilsan-Paik Hospital, Goyang, Korea

10. Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea

11. Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea

12. Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea

13. Kidney Research Institute, Seoul National University, Seoul, Korea

Publisher

The Korean Society of Nephrology

Subject

Urology,Nephrology

Link

http://pdf.medrang.co.kr/KRCP2/2017/036/KRCP036-01-09.pdf

Reference32 articles.

1. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES)

2. ESRD Registry Committee, Korean Society of Nephrology 2016. Current renal replacement therapy in Korea - Insan Memorial Dialysis Registry, 2015., The 36th Annual Meeting of the Korean Society of Nephrology, 2016, Seoul.

3. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

4. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study

5. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: A Randomized Controlled Study of Benazepril and Losartan in Chronic Renal Insufficiency

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indoxyl Sulfate-Induced Macrophage Toxicity and Therapeutic Strategies in Uremic Atherosclerosis;Toxins;2024-05-31

2. AST-120 improved uremic pruritus by lowering indoxyl sulfate and inflammatory cytokines in hemodialysis patients;Aging;2024-02-21

3. Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees;Clinical and Experimental Nephrology;2024-02-10

4. Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis;Physiological Reviews;2023-10-01

5. Relationship between urinary potassium excretion, serum potassium levels and cardiac injury in non-dialysis chronic kidney disease: KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD);British Journal of Nutrition;2023-09-11